New immunotherapy to target blood cancers, solid tumors
Natural killer cells treatment offers the potential for an effective, safer treatment option than most current immunotherapies.
Natural killer cells treatment offers the potential for an effective, safer treatment option than most current immunotherapies.
Israel-based Belong.Life adds anonymous support group to its app where members can have chats with medical experts about COVID-19 concerns.
Whether it’s in diagnostics, treatment or care management, Israel’s innovators are busy inventing and adapting technologies to ease the coronavirus burden on the world.
Volunteers set to provide medical aid, logistical assistance and emotional support for those stuck at home.
Israel’s Vocalis Health is collecting voice samples of Covid-19 patients and healthy individuals to develop a new screening method.
Method may enable the authorities to focus efforts on areas where an outbreak is anticipated and relieve measures taken in others.
Researcher Avi Schroeder’s technology for shellfish could protect us against coronavirus. He’s also working on a cancer drug from an elephant protein.
A survey of one Israeli hospital’s oncology staff on the impact of Dream Doctors medical clowns reveals some eye-opening insights.
Coronavirus isn’t the first pandemic to hit our region. Ironically, disease has always helped in creating modern health systems, including Israel’s.
Nanox, based in Israel and Japan, is poised to digitize, democratize and totally revolutionize 125-year-old X-ray technology.
Teva Pharmaceuticals to donate 6 million hydroxychloroquine tablets through wholesalers to hospitals by March 31, and 10 million within a month.
A hospital lab kit to diagnose COVID-19 in 50 minutes is nearing the market, while a home kit will be ready within four months, says BATM founder.
Technion and Rambam Health Care Campus scientists present a novel way to test more than 60 patients simultaneously.
Israel sends medical and protective gear to PA colleagues and organizes online professional workshops for medical personnel on both sides.
Talicia from RedHill Biopharma is the first new FDA-approved drug in more than a decade for the gastrointestinal H. pylori infection in adults.